Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial-Reference-Cited by-同舟云学术

Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial

Published:2018-12 Issue:12 Volume:5 Page:e641-e652
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Biondi Andrea,Gandemer Virginie,De Lorenzo Paola,Cario Gunnar,Campbell Myriam,Castor Anders,Pieters Rob,Baruchel André,Vora Ajay,Leoni Veronica,Stary Jan,Escherich Gabriele,Li Chi-Kong,Cazzaniga Giovanni,Cavé Hélène,Bradtke Jutta,Conter Valentino,Saha Vaskar,Schrappe Martin,Grazia Valsecchi Maria

Publisher

Elsevier BV

Subject

Hematology

Reference26 articles.

1. Treatment of acute lymphoblastic leukemia;Pui;N Engl J Med,2006

2. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster;Schrappe;Leukemia,2000

3. Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005;Aricò;J Clin Oncol,2010

4. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia;Aricò;N Engl J Med,2000

5. Advances in therapy for Philadelphia-positive acute lymphoblastic leukemia of childhood and adolescence;Bleckmann;Br J Haematol,2016

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of Measurable Residual Disease in Adult Philadelphia Chromosome–Positive ALL: A GRAAPH-2014 Study;Journal of Clinical Oncology;2024-09-10

2. Case report: An intriguing case of Philadelphia chromosome–positive acute lymphoblastic leukemia recurrence;Frontiers in Oncology;2024-07-31

3. Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experience;HemaSphere;2024-07

4. Acute lymphoblastic leukaemia;Nature Reviews Disease Primers;2024-06-13

5. Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain;Blood;2024-05-23